PCT

PCT is not an imaginary-business short. The product and demand appear real. The problem is whether the process can produce acceptable material at a cost that supports an actual business rather than a permanently subsidized demonstration.

A reported cost estimate several times the price of virgin plastic is the center of the bear case. If that estimate is directionally right, demand alone does not rescue the economics.

PureCycle licenses a polypropylene recycling process originally developed by Procter & Gamble. The history raises an obvious question: if the process is so attractive, why was the technology transferred instead of scaled inside P&G?

The market can confuse regulatory enthusiasm and customer demand for recycled material with proof that PCT can manufacture it reliably and profitably. Those are three separate claims.

Low historical dilution is not automatically comforting for a cash-burning company. It makes me ask where the capital is coming from and what claims may sit ahead of common shareholders.

I do not know this technology or market well enough to pretend high confidence. The investor community also appears more rational than the communities around some of my other shorts, and the trade can be crowded and expensive.

• PCT demonstrates repeatable, high-quality production with credible unit economics.
• Cash burn falls materially without starving the manufacturing ramp.
• Revenue grows enough that the valuation is no longer detached from commercial output.